Docs are finally waking up to one of the biggest scams in medicine — one you may have been a victim of yourself.
The very meds that are supposed to “control” cholesterol can bring your levels down far too low.
Even many mainstream physicians are starting to back off. And the drug industry is absolutely livid.
Big Pharma and its apologists are fighting back with a NEW scam — and it’s one you need to watch out for before it’s used to push you into taking newer, more powerful, and far more dangerous drugs for cholesterol control.
They’re out with a new study that says docs need to stop fussing over cholesterol that’s “too low,” despite the notorious risks of rock-bottom LDL levels.
They even claim there’s NO SUCH THING as “too low!”
I have to wonder if they’re suffering from one of the notorious risks of low cholesterol.
That’s memory loss — because years of science has made it beyond clear that there certainly IS such a thing as “too low.”
It’s more likely, however, that they’re suffering from something else.
That’s a classic case of research bias.
The study was funded by Amgen, the company behind a new $14,000-a-year cholesterol drug known to bring LDL down to shockingly low levels. They have a vested interest in making people think those levels are safe, which would explain why patients in the study took the drug for an average of just 2.2 years.
That’s not even close to what you need to expose the true risks.
Many of the studies linking statin drugs for cholesterol to diabetes, for example, lasted nearly THREE TIMES longer than this one!
Clearly, 2.2 years just isn’t long enough when it comes to establishing the risks of cholesterol meds, and not just for diabetes. Other possible risks of low cholesterol such as cancer and dementia don’t develop overnight, or even over 2.2 years.
They can take DECADES to develop.
And that’s how long you’re supposed to take these drugs. Like statins, the new drug is supposed to be a lifetime commitment.
That means 2.2 years is just the beginning.
In any case, LDL levels alone aren’t a true picture of your health or your heart risks. Sure, they can be too high — or too low — but no doc should ever use that number by itself to make important treatment decisions.
I’m just as concerned by particle size and oxidation levels, and any doc who doesn’t take these factors into consideration is missing crucial pieces of the puzzle.